Every 10-Q that United Natural Foods Inc (UNFI) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow UNFI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full UNFI filings page.
United Natural Foods, Inc. posted improved profitability in its fiscal third quarter despite lower sales. Net sales were $7,723 million, down from $8,059 million a year earlier, but net income swung to $33 million from a $7 million loss. Diluted earnings per share were $0.52 versus a loss of $0.12.
For the 39‑week period, net sales were $23,510 million compared with $24,088 million, while net income improved to $49 million from a $31 million loss, with diluted EPS of $0.78. Operating cash flow strengthened to $343 million, supporting capital spending of $100 million and repayments of long‑term debt and finance leases of $130 million, reducing long‑term debt to $1,660 million.
The company recorded restructuring, integration and closed‑property costs of $40 million year‑to‑date and non‑cash asset impairments of $29 million, while also recognizing $22 million of cybersecurity‑related costs offset by $40 million of insurance recoveries. It accrued a $23.4 million opioid MDL settlement and a $39 million securities class‑action settlement (funded by insurers). Subsequent to quarter‑end, UNFI sold a surplus distribution center and expects an $18 million gain, using proceeds to repay ABL borrowings.
United Natural Foods, Inc. reported a return to profitability for the 13-week period ended January 31, 2026, with net sales of $7,947 million versus $8,158 million a year earlier and net income attributable to the company of $20 million compared to a $3 million loss.
Operating income rose to $57 million from $27 million, aided by lower operating expenses and higher Adjusted EBITDA of $179 million versus $145 million. Year-to-date, net sales were $15,787 million, net income attributable to the company was $16 million versus a $24 million loss, and Adjusted EBITDA increased to $346 million from $279 million.
The company generated $245 million of operating cash flow in the first 26 weeks versus $137 million previously, reduced long-term debt (including current portion) to $1,716 million from $1,862 million, and ended the period with $52 million in cash. It recorded $21 million of year-to-date cybersecurity incident costs and received $20 million of related insurance proceeds, plus an additional $10 million after quarter-end. UNFI also agreed to settle opioid-related cases for $23.4 million and continued its network optimization and retail store rationalization efforts.
United Natural Foods, Inc. reported first-quarter fiscal 2026 net sales of $7,840 million, essentially flat versus $7,871 million a year earlier, as modest growth in the Natural segment offset softer Conventional and Retail sales. Gross profit edged up to $1,051 million, and operating income improved to $19 million from $5 million as operating expenses declined.
The company reduced its net loss attributable to common shareholders to $4 million, or $(0.06) per share, compared with a $21 million loss, or $(0.35) per share, in the prior-year quarter. Adjusted EBITDA by segment rose, led by Natural and Conventional, even as Retail posted a small Adjusted EBITDA loss.
Operating activities used $38 million of cash, an improvement from a $110 million use a year ago, while capital spending fell to $16 million. Long-term debt including current portion increased to $1,920 million, with the asset-based lending facility balance at $1,057 million and $1,289 million of unused credit available.
During the quarter UNFI recognized $14 million of costs related to a previously disclosed cybersecurity incident and recorded $10 million of related insurance recoveries. It also accrued a $23.4 million liability for a proposed settlement of opioid-related multidistrict litigation.